geoFish offers a broad range of medical marketing services to support the success of your project or brand
I am Geoff Fisher, a medical affairs specialist with over 20 years experience in the pharma industry. I am passionate about customers and my offerings are centred around helping develop robust strategy, tactics, and communications for drug development and medical marketing activities that deliver high value to patients, clinicians, payers and regulators. My diverse service offering reflects the breadth and depth of my expertise and experience in major pharma. I have a blend of experience across senior global roles in clinical development, medical affairs/marketing, and communications, spanning all phases of development from pre-clinical to post-marketing, covering a range of therapy areas, including oncology, anaesthesia/analgesia and gastroenterology. My experience has spanned North America, Europe, Japan and emerging markets including China. Please click on ‘ABOUT GEOFISH’ above to find out more.
My services span all stages of the drug development and marketing spectrum and include: market opportunity analysis and development of target product profiles and claims at a disease area and asset level; competitive intelligence and analysis, including war games/deep dives and market event impact analysis; customer validation of strategy (e.g. advisory boards, shaping of market research); medical marketing analysis of market entry and life cycle opportunities; medical evidence plans; optimisation of brand communications, including development of science story, key messages, promotional claims, brand news, symposia content and other marketing materials.
Please click on ‘SERVICES’ above to find out more about the questions I can help you answer and my menu of services. I have access to an extensive network, so can bring in high calibre experts from other fields to help complete specific projects. Click on ‘WHY GEOFISH?’ to find out more. Please don’t hesitate to contact me by telephone, or email, if you would like further information.